BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 31296923)

  • 21. Elevated preoperative carcinoembryonic antigen (CEA) and Ki67 is predictor of decreased survival in IIA stage colon cancer.
    Peng Y; Wang L; Gu J
    World J Surg; 2013 Jan; 37(1):208-13. PubMed ID: 23052808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preoperative serum markers for individual patient prognosis in stage I-III colon cancer.
    Giessen-Jung C; Nagel D; Glas M; Spelsberg F; Lau-Werner U; Modest DP; Schulz C; Heinemann V; Di Gioia D; Stieber P
    Tumour Biol; 2015 Sep; 36(10):7897-906. PubMed ID: 25953265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Significance of Preoperative Serum Carcinoembryonic Antigen Within the Normal Range in Colorectal Cancer Patients Undergoing Curative Resection.
    Beom SH; Shin SJ; Kim CG; Kim JH; Hur H; Min BS; Lee KY; Kim NK; Ahn JB
    Ann Surg Oncol; 2020 Aug; 27(8):2774-2783. PubMed ID: 32180063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjuvant chemotherapy benefits on patients with elevated carcinoembryonic antigen in stage IIA colon cancer: a SEER-based analysis.
    Zhou H; Wang S; Cai Z; Qiu E; Chen Q; Rao X; Han S; Li Z
    Int J Colorectal Dis; 2022 Dec; 37(12):2481-2489. PubMed ID: 36334109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of carcinoembryonic antigen distribution in tumor tissue of colorectal carcinoma.
    Nazato DM; Matos LL; Waisberg DR; Souza JR; Martins LC; Waisberg J
    Arq Gastroenterol; 2009; 46(1):26-31. PubMed ID: 19466306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T4 stage and preoperative anemia as prognostic factors for the patients with colon cancer treated with adjuvant FOLFOX chemotherapy.
    An MS; Yoo JH; Kim KH; Bae KB; Choi CS; Hwang JW; Kim JH; Kim BM; Kang MS; Oh MK; Hong KH
    World J Surg Oncol; 2015 Feb; 13():64. PubMed ID: 25889520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis.
    Vernieri C; Galli F; Ferrari L; Marchetti P; Lonardi S; Maiello E; Iaffaioli RV; Zampino MG; Zaniboni A; De Placido S; Banzi M; Damiani A; Ferrari D; Rosati G; Labianca RF; Bidoli P; Frassineti GL; Nicolini M; Pavesi L; Tronconi MC; Buonadonna A; Ferrario S; Re GL; Adamo V; Tamburini E; Clerico M; Giordani P; Leonardi F; Barni S; Ciarlo A; Cavanna L; Gori S; Cinieri S; Faedi M; Aglietta M; Antista M; Dotti KF; Galli F; Di Bartolomeo M;
    Oncologist; 2019 Mar; 24(3):385-393. PubMed ID: 30606884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of the ratio of carcinoembryonic antigen concentration to maximum tumor diameter in patients with stage II colorectal cancer.
    Li X; Xiong Z; Xie M; Huang Q; Jin L; Yin S; Chen S; Lan P; Lian L
    J Gastrointest Oncol; 2021 Aug; 12(4):1470-1481. PubMed ID: 34532103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transient elevation in serum carcinoembryonic antigen while on adjuvant chemotherapy for colon cancer: Is this of prognostic importance?
    Lawrence N; Hinder V; Murray M; Macapagal J; Thompson P; Sharples K; Findlay M
    Asia Pac J Clin Oncol; 2017 Apr; 13(2):e124-e131. PubMed ID: 26245738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship Between Metformin Use and Recurrence and Survival in Patients With Resected Stage III Colon Cancer Receiving Adjuvant Chemotherapy: Results From North Central Cancer Treatment Group N0147 (Alliance).
    Singh PP; Shi Q; Foster NR; Grothey A; Nair SG; Chan E; Shields AF; Goldberg RM; Gill S; Kahlenberg MS; Sinicrope FA; Sargent DJ; Alberts SR
    Oncologist; 2016 Dec; 21(12):1509-1521. PubMed ID: 27881709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carcinoembryonic antigen as a marker of radioresistance in colorectal cancer: a potential role of macrophages.
    Huang EY; Chang JC; Chen HH; Hsu CY; Hsu HC; Wu KL
    BMC Cancer; 2018 Mar; 18(1):321. PubMed ID: 29580202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preoperative carcinoembryonic antigen level as an independent prognostic factor in potentially curative colon cancer.
    Huh JW; Oh BR; Kim HR; Kim YJ
    J Surg Oncol; 2010 Apr; 101(5):396-400. PubMed ID: 20119979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjuvant therapy with fluorouracil and oxaliplatin in stage II and elderly patients (between ages 70 and 75 years) with colon cancer: subgroup analyses of the Multicenter International Study of Oxaliplatin, Fluorouracil, and Leucovorin in the Adjuvant Treatment of Colon Cancer trial.
    Tournigand C; André T; Bonnetain F; Chibaudel B; Lledo G; Hickish T; Tabernero J; Boni C; Bachet JB; Teixeira L; de Gramont A
    J Clin Oncol; 2012 Sep; 30(27):3353-60. PubMed ID: 22915656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic factors and the role of adjuvant chemotherapy in post-curative surgery for Dukes B and C colon cancers and survival outcomes: a Malaysian experience.
    Hassan AS; Naicker M; Yusof KH; Wan Ishak WZ
    Asian Pac J Cancer Prev; 2015; 16(6):2237-43. PubMed ID: 25824744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preoperative carcinoembryonic antigen predicts outcomes in node-negative colon cancer patients: a multivariate analysis of 572 patients.
    Harrison LE; Guillem JG; Paty P; Cohen AM
    J Am Coll Surg; 1997 Jul; 185(1):55-9. PubMed ID: 9208961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delivery of Adjuvant Oxaliplatin for Colon Cancer: Insights From Routine Clinical Practice.
    Satkunam N; Wei X; Biagi JJ; Nanji S; Booth CM
    J Natl Compr Canc Netw; 2016 Dec; 14(12):1548-1554. PubMed ID: 27956539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic impact of carcinoembryonic antigen and carbohydrate antigen 19-9 in stage IV colorectal cancer patients after R0 resection.
    Abe S; Kawai K; Ishihara S; Nozawa H; Hata K; Kiyomatsu T; Tanaka T; Watanabe T
    J Surg Res; 2016 Oct; 205(2):384-392. PubMed ID: 27664887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of pretreatment carcinoembryonic antigen after definitive radiotherapy with or without concurrent chemotherapy for squamous cell carcinoma of the uterine cervix.
    Huang EY; Hsu HC; Sun LM; Chanchien CC; Lin H; Chen HC; Tseng CW; Ou YC; Chang HY; Fang FM; Huang YJ; Wang CY; Lu HM; Tsai CC; Ma YY; Fu HC; Wang YM; Wang CJ
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1105-13. PubMed ID: 20932670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preoperative carcinoembryonic antigen level as an independent prognostic factor in colorectal cancer: Taiwan experience.
    Wang WS; Lin JK; Chiou TJ; Liu JH; Fan FS; Yen CC; Lin TC; Jiang JK; Yang SH; Wang HS; Chen PM
    Jpn J Clin Oncol; 2000 Jan; 30(1):12-6. PubMed ID: 10770562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Real-world cost-effectiveness of oxaliplatin in stage III colon cancer: a synthesis of clinical trial and daily practice evidence.
    van Gils CW; de Groot S; Redekop WK; Koopman M; Punt CJ; Uyl-de Groot CA
    Pharmacoeconomics; 2013 Aug; 31(8):703-18. PubMed ID: 23657918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.